1xgi

From Proteopedia
Revision as of 06:56, 21 November 2007 by OCA (talk | contribs) (New page: left|200px<br /><applet load="1xgi" size="450" color="white" frame="true" align="right" spinBox="true" caption="1xgi, resolution 1.96Å" /> '''AmpC beta-lactamase ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
File:1xgi.gif


1xgi, resolution 1.96Å

Drag the structure with the mouse to rotate

AmpC beta-lactamase in complex with 3-(3-nitro-phenylsulfamoyl)-thiophene-2-carboxylic acid

OverviewOverview

Bacterial expression of beta-lactamases is the most widespread resistance, mechanism to beta-lactam antibiotics, such as penicillins and, cephalosporins. There is a pressing need for novel, non-beta-lactam, inhibitors of these enzymes. One previously discovered novel inhibitor of, the beta-lactamase AmpC, compound 1, has several favorable properties: it, is chemically dissimilar to beta-lactams and is a noncovalent, competitive, inhibitor of the enzyme. However, at 26 microM its activity is modest., Using the X-ray structure of the AmpC/1 complex as a template, 14, analogues were designed and synthesized. The most active of these, compound 10, had a K(i) of 1 microM, 26-fold better than the lead. To, understand the origins of this improved activity, the structures of AmpC, in complex with compound 10 and an analogue, compound 11, were determined, by X-ray crystallography to 1.97 and 1.96 A, respectively. Compound 10 was, active in cell culture, reversing resistance to the third generation, cephalosporin ceftazidime in bacterial pathogens expressing AmpC. In, contrast to beta-lactam-based inhibitors clavulanate and cefoxitin, compound 10 did not up-regulate beta-lactamase expression in cell culture, but simply inhibited the enzyme expressed by the resistant bacteria. Its, escape from this resistance mechanism derives from its dissimilarity to, beta-lactam antibiotics.

About this StructureAbout this Structure

1XGI is a Single protein structure of sequence from Escherichia coli with NST as ligand. Active as Beta-lactamase, with EC number 3.5.2.6 Full crystallographic information is available from OCA.

ReferenceReference

Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture., Tondi D, Morandi F, Bonnet R, Costi MP, Shoichet BK, J Am Chem Soc. 2005 Apr 6;127(13):4632-9. PMID:15796528

Page seeded by OCA on Wed Nov 21 06:03:49 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA